Vaccine characterization using advanced technology

BioPharm International

Volumn 20, Issue 8 SUPPL., 2007, Pages

  Becht, Steven ^a   Gu, Xuelin ^a   Ding, Xiaoya ^a  

^a cGMP Laboratory of PPD

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; INACTIVATED VACCINE; LIVE VACCINE; VACCINE;

DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFICACY; DRUG MANUFACTURE; DRUG MONITORING; DRUG SAFETY; ELECTROSPRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL ELECTROPHORESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH MEASUREMENT; PHYSICAL CHEMISTRY; QUALITY CONTROL; REVIEW; THERMOGRAVIMETRY; UNSPECIFIED SIDE EFFECT; VACCINE PRODUCTION;

EID: 34548220094     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. US Food and Drug Administration. Guidance for Industry. Characterization and qualification of cell substrates and other biological starting materials used in the production of viral vaccines for the prevention and treatment of infectious diseases. Rockville, MD: 2006 Sept.
2. US FDA. Innovation stagnation: challenge and opportunity on the critical path to new medical products. Rockville, MD: 2005 Mar.
3. Word Health Organization. Drafting group on stability of vaccines guidelines: Report of the 2nd meeting. Geneva, Switzerland: 2004 June 16-17.
4. Goodman JL. Vaccine safety: vision for the future. Presentation at FDA vaccine safety workshop. 2007 Apr 10.
5. WHO Guidelines on Nonclinical Evaluation of Vaccines, WHO Technical Report Series, No. 927. Geneva: 2005.
6. Knezevic I. Potency Assays for Novel Vaccines: WHO Expectations. NIH meeting: Assaying potency of novel vaccines. 2005 Oct 11-12; Bethesda, MD.
7. Gavin D. Perspectives on potency assays for complex biological products. 2007 WCBP, CMC Forum on Bioassays, 2007 Jan 28; Washington, DC.
8. WHO. Immunization, vaccines and biologicals: strategic plan 2006-2009. Geneva: 2005 Dec.
9. WHO. Recommendations for the preparation, characterization and establishment of international and other biological reference standards, final draft. Adopted by the 55th meeting of the WHO expert committee on biological standardization. Geneva: 2004 Nov 15-18.
10. International Conference on Harmonization. Q6B, Specifications: Test procedures and acceptance criteria for biotechnological/biological products. Geneva, Switzerland:1999 Mar 10.
11. ICH. Q5C, Quality of biotechnological products: stability testing of biotechnological/biological products. Geneva: 1995 Nov 30.
12. ICH. Q5D, Derivation and characterization of cell substrates used for production of biotechnological/biological products. Geneva: 1997 July 16.
13. ICH. Q5E, Comparability of biotechnological/biological products subject to changes in their manufacturing process.Geneva: 2004 Nov 18.
14. Girard MP et al. A review of human vaccine research and development: Malaria. Vaccine. 2007; 25:1567-1580.